3TN-30256-55038
3 vaccinations
5 coded responses
27 check-ins
5 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 36-40
- ZIP prefix
- 750 / TX
- Registered
- 2021-01-04
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-04
Registered in v-safe
-
2021-01-04
Dose 1 — Moderna
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-18
- 2021-01-25
-
2021-02-01
Survey response — day 28, dose 1MedDRA: Headache, Nasal congestion, Pre-existing disease, Self-medication — Feeling: GoodFree text: Mild headache, mild nasal congestion, both relieved by OTC medicine and resolved in a few hours. (Note: there are seasonal allergens to which I react present in North Texas at this time of year.)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-02
Dose 2 — Moderna
-
2021-02-03
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: lymphatic node swellingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-16
-
2021-05-04
Survey response — 3 months, dose 2MedDRA: Feeling abnormal — Feeling: GoodFree text: Brief period (24 hours) of feeling slightly ill, no respiratory symptoms or fever. No lasting symptoms.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-03
-
2021-08-17
Dose 3 — Moderna
-
2021-11-16
Survey response — 3 months, dose 3MedDRA: Pharyngitis bacterial, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Bacterial pharyngitis (severe), resolved with antibiotics. (PCR nasal swab tested negative for SARS-CoV-2 at height of symptomatic pharyngitis.)MedDRA releases: 2024-11 · check-in free text available
-
2021-11-16
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-11-17
- 2022-02-15
-
2022-08-17
Survey response — 12 months, dose 3MedDRA: Tonsillitis bacterial — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Bacterial tonsillitis, infection cleared with routine oral antibiotics without complications.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-17
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-08-18
- 2022-08-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Moderna | |
| 2 | 2021-02-02 | Moderna | |
| 3 | 2021-08-17 | Moderna | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 3 — day 28, dose 1
Symptoms: Mild headache, mild nasal congestion, both relieved by OTC medicine and resolved in a few hours. (Note: there are seasonal allergens to which I react present in North Texas at this time of year.)
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): lymphatic node swelling
Release 8 — 3 months, dose 2
Symptoms: Brief period (24 hours) of feeling slightly ill, no respiratory symptoms or fever. No lasting symptoms.
Release 10 — 3 months, dose 3
Symptoms: Bacterial pharyngitis (severe), resolved with antibiotics. (PCR nasal swab tested negative for SARS-CoV-2 at height of symptomatic pharyngitis.)
Release 12 — 12 months, dose 3
Symptoms: Bacterial tonsillitis, infection cleared with routine oral antibiotics without complications.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Feeling abnormal | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Pharyngitis bacterial | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Self-medication | ✓ | ✓ | ✓ |
| SD | Tonsillitis bacterial | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release